Rubber composition, method for preventing discoloration of rubber composition, and tire
US-9200141-B2 · Dec 1, 2015 · US
US2016362535A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016362535-A1 |
| Application number | US-201615248953-A |
| Country | US |
| Kind code | A1 |
| Filing date | Aug 26, 2016 |
| Priority date | May 2, 2011 |
| Publication date | Dec 15, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A composition, which comprises a) an organic material susceptible to oxidative, thermal or light-induced degradation; and b) a compound of formula I (Formula I) (I) where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are independently from each other H, C 1 -C 8 -alkyl, C 4 -C 8 -cycloalkyl, phenyl, C 1 -C 4 -alkoxy or halogen; n is 1, 2, 3, or 4; and when n is 1 A is —C(=0)-OR′ 1 , —C(=0)-N(R ′2 )(R′ 3 ), —CN, phenyl, which is unsubstituted or substituted by one or more C 1 -C 8 -alkyl, C 4 -C 8 -alkoxy, C 5 -C 7 -cycloalkyl or halogen, —H or —S0 2 -phenyl; when n is 2 A is —C(=0)-0-Z 1 —O—C(=0)-, —C(=0)-N(R″ 1 )—Z 2 —N(R″ 2 )—C(=0)- or piperazine-N,N′-biscarbonyl.
Opening claim text (preview).
1 . A composition, which comprises a) a polyolefin, a polyether polyol, or a polyurethane; and b) a compound of formula I wherein n is 1 or 2; when n is 1, A is —C(═O)—OR′ 1 , —C(═O)—N(R′ 2 )(R′ 3 ), —CN, phenyl which is unsubstituted or substituted by one or more C 1 -C 8 -alkyl, C 1 -C 4 -alkoxy, C 5 -C 7 -cycloalkyl or halogen, —H or —SO 2 -phenyl; and when n is 2, A is —C(═O)—O—Z 1 —O—C(═O)—, —C(═O)—N(R″ 1 )—Z 2 —N(R″ 2 )—C(═O)— or piperazine-N,N′-biscarbonyl; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are independently from each other H, C 1 -C 8 -alkyl, C 4 -C 8 -cycloalkyl, phenyl, C 1 -C 4 -alkoxy or halogen; R′ 1 is H, C 1 -C 22 -alkyl, C 2 -C 18 -alkenyl, C 3 -C 12 -alkine-yl, C 4 -C 8 -cycloalkyl which is unsubstituted or substituted by one to three C 1 -C 4 -alkyl, C 4 -C 8 -cycloalkyl-C 1 -C 4 -alkyl bicyclic or tricyclic C 5 -C 20 -alkyl, C 6 -C 14 -aryl-C 1 -C 4 -alkyl, C 2 -C 12 -alkyl which is substituted by one or more hydroxyl groups, C 4 -C 12 -alkyl which is interrupted by one or more oxygen atoms, C 4 -C 18 -alkyl which is interrupted by one sulfur atom, 2,2,6,6-tetramethylpiperidine-4-yl, 1-(C 1 -C 8 -alkyl)-2,2,6,6-tetramethylpiperidine-4-yl or 1-(C 1 -C 8 -alkoxy)-2,2,6,6-tetramethylpiperidine-4-yl; R′ 2 and R′ 3 are independently from each other H, C 1 -C 22 -alkyl, C 2 -C 18 -alkenyl, C 4 -C 8 -cycloalkyl which is unsubstituted or substituted by one to three C 1 -C 4 -alkyl, C 6 -C 10 -aryl, C 4 -C 8 -cycloalkyl-C 1 -C 4 -alkyl, C 6 -C 14 -aryl-C 1 -C 4 -alkyl, C 2 -C 8 -alkyl which is substituted by one hydroxyl group, 2,2,6,6-tetramethylpiperidine-4-yl, 1-(C 1 -C 8 -alkyl)-2,2,6,6-tetramethylpiperidine-4-yl or 1-(C 1 -C 8 -alkoxy)-2,2,6,6-tetramethylpiperidine-4-yl, or R′ 2 and R′ 3 form together with the nitrogen atom to which they are attached a 5-, 6- or 7-membered saturated heterocycle; R″ 1 and R″ 2 are independently from each other H, C 1 -C 22 -alkyl, C 2 -C 18 -alkenyl, C 4 -C 8 -cycloalkyl which is unsubstituted or substituted by one to three C 1 -C 4 -alkyl, C 4 -C 8 -cycloalkyl-C -C 4 -alkyl or C 6 -C 14 -aryl-C 1 -C 4 -alkyl; Z 1 is C 2 -C 12 -alkylene, C 4 -C 8 -cycloalkylene, C 4 -C 8 -cycloalkane-bis-(C 1 -C 4 -alkylene), C 6 -C 14 -arene-bis-(C 1 -C 4 -alkylene), C 3 -C 6 -alkylene which is substituted by one or more hydroxyl groups, C 4 -C 12 -alkylene which is interrupted by one or more oxygen atoms, hexahydro-furo[3,2-b]furane-3,6-diyl, C 4 -C 8 -alkylene which is interrupted by a sulfur atom, 3-(C 1 -C 8 -alkyl)-3-azapentane-1,5-diyl, 4-(C 1 -C 8 -alkyl)-4-azaheptane-1,7-diyl or 1-ethyl-2,2,6,6-tetramethylpiperidine-4,2′-diyl; and Z 2 is C 2 -C 12 -alkylene, C 4 -C 8 -cycloalkylene, C 6 -C 14 -arylene, C 4 -C 8 -cycloalkane-bis(C 1 -C 4 -alkylene), C 6 -C 14 -arene-bis-(C 1 -C 4 -alkylene), C 4 -C 12 -alkylene which is interrupted by one or more oxygen atoms, 3-(C 1 -C 8 -alkyl)-3-azapentane-1,5-diyl or 4-(C 1 -C 8 -alkyl)-4-azaheptane-1,7-diyl. 2 . A composition according to claim 1 , where in the compound of formula I, n is 1 or 2 when n is 1, A is —C(═O)—OR′ 1 , —C(═O)—N(R′ 2 )(R′ 3 ), —CN, phenyl which is unsubstituted or substituted by one to three C 1 -C 8 -alkyl or C 1 -C 4 -alkoxy, —H or —SO 2 -phenyl; when n is 2, A is —C(═O)—O—Z 1 —O—C(═O)—, —C(═O)—N(R″ 1 )—Z 2 —N(R″ 2 )—C(═O)— or piperazine-N,N′-biscarbonyl; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are independently from each other H, C 1 -C 8 -alkyl, phenyl or C 1 -C 4 -alkoxy with the proviso that at least R 1 or R 5 is H and at least R 6 or R 10 is H; R′ 1 is H, C 1 -C 22 -alkyl, C 2 -C 18 -alkenyl, C 5 -C 7 -cycloalkyl which is unsubstituted or substituted by one C 1 -C 4 -alkyl, C 5 -C 7 -cycloalkyl-C 1 -C 4 -alkyl, C 6 -C 10 -aryl-C 1 -C 4 -alkyl, C 4 -C 12 -alkyl which is interrupted by one or more oxygen atoms, 2,2,6,6-tetramethylpiperidine-4-yl, 1-(C 1 -C 6 -alkyl)-2,2,6,6-tetramethylpiperidine-4-yl or 1-(C 1 -C 6 -alkoxy)-2,2,6,6-tetramethylpiperidine-4-yl; R′ 2 and R′ 3 are independently from each other H, C 1 -C 22 -alkyl, C 2 -C 18 -alkenyl, C 5 -C 7 -cycloalkyl which is unsubstituted or substituted by one C 1 -C 4 -alkyl, C 6 -C 10 -aryl, C 5 -C 7 -cycloalkyl-C 1 -C 4 -alkyl, C 6 -C 10 -aryl-C 1 -C 4 -alkyl, 2,2,6,6-tetramethylpiperidine-4-yl, 1-(C 1 -C 6 -alkyl)-2,2,6,6-tetramethylpiperidine-4-yl or 1-(C 1 -C 6 -alkoxy)-2,2,6,6-tetramethylpiperidine-4-yl, or R′ 2 and R′ 3 form together with the nitrogen atom to which they are attached a pyrrolidine, a piperidine or a morpholine; R″ 1 and R″ 2 independently from each other H, C 1 -C 22 -alkyl, C 2 -C 18 -alkenyl, C 5 -C 7 -cycloalkyl which is unsubstituted or substituted by one C 1 -C 4 -alkyl, C 5 -C 7 -cycloalkyl-C 1 -C 4 -alkyl or C 6 -C 10 -aryl-C 1 -C 4 -alkyl; Z 1 is C 2 -C 12 -alkylene, C 5 -C 7 -cycloalkylene, C 5 -C 7 -cycloalkane-bis-(C 1 -C 4 -alkylene), C 6 -C 10 -arene-bis-(C 1 -C 4 -alkylene), C 3 -C 6 -alkylene which is substituted by one or more hydroxyl groups, C 4 -C 12 -alkylene which is interrupted by one or more oxygen atoms, C 4 -C 8 -alkylene which is interrupted by a sulfur atom, 3-(C 1 -C 4 -alkyl)-3-azapentane-1,5-diyl, 4-(C 1 -C 4 -alkyl)-4-azaheptane-1,7-diyl or 1-ethyl-2,2,6,6-tetramethylpiperidine-4,2′-diyl; and Z 2 is C 2 -C 12 -alkylene, C 5 -C 7 -cycloalkylene, C 6 -C 14 -arylene, C 5 -C 7 -cycloalkane-bis(C 1 -C 4 -alkylene), C 6 -C 10 -arene-bis-(C 1 -C 4 -alkylene), C 4 -C 12 -alkylene which is interrupted by one or more oxygen atoms, 3-(C 1 -C 4 -alkyl)-3-azapentane-1,5-diyl or 4-(C 1 -C 4 -alkyl)-4-azaheptane-1,7-diyl. 3 . A composition according to claim 1 , where in the compound of formula I, n is 1 or 2; when n is 1, A is —C(═O)—OR′ 1 , —C(═O)—N(R′ 2 )(R′ 3 ), —CN, phenyl, —H or —SO 2 -phenyl; when n is 2, A is —C(═O)—O—Z 1 —O—C(═O)—; n is 1 or 2; R 1 , R 2 , R 4 , R 5 , R 6 , R 7 , R 9 and R 10 are H; R 3 and R 8 are independently from each other H or C 1 -C 4 -alkoxy; R′ 1 is H, C 1 -C 12 -alkyl, C 5 -C 7 -cycloalkyl which is unsubstituted, phenyl-C 1 -C 4 -alkyl, 1-(C 1 -C 6 -alkyl)-2,2,6,6-tetramethylpiperidine-4-yl or 1-(C 1 -C 6 -alkoxy)-2,2,6,6-tetramethylpiperidine-4-yl; R′ 2 and R′ 3 are independently from each other H, C 1 -C 12 -alkyl, C 5 -C 7 -cycloalkyl which is unsubstituted, C 6 -C 10 -aryl, phenyl-C 1 -C 4 -alkyl, 1-(C 1 -C 6 -alkyl)-2,2,6,6-tetramethylpiperidine-4-yl or 1-(C 1 -C 6 -alkoxy)-2,2,6,6-tetramethylpiperidine-4-yl, or R′ 2 and R′ 3 form together with the nitrogen atom to which they are attached a pyrrolidine, a piperidine or a morpholine; and Z 1 is C 5 -C 7 -cycloalkylene. 4 .- 6 . (canceled) 7 . A composition according to claim 1 , wherein component b) is contained in an amount of 0.005% to 10% based on the weight of component a). 8 . A composition according to claim 1 , c) a further additive. 9 . A composition according to claim 8 , which comprises c) an additive selected from the group consisting of a phosphite, a phosphonite, an acid scavenger, a phenolic antioxidant, and an aminic antioxidant. 10 . A composition according to claim 8 , wherein the weight ratio of b) to c) is from 4:1 to 1:20. 11 . A composition according to claim 9 , which comprises d) a second further additive selected from the group consisting of a phosphite, a phosphonite, an acid scavenger, a phenolic antioxidant and an aminic antioxidant. 12 . A process for protection of a polyolefin, a polyether polyol, or a polyurethane susceptible to oxidative, thermal or light-induced degradation, w
containing sulfur and oxygen · CPC title
containing nitrogen and oxygen · CPC title
Five-membered rings · CPC title
Phenols; Phenolates · CPC title
with hydroxyaryl compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.